RLAY vs SLS Stock Comparison

SLS currently leads RLAY in this stock comparison, with AIQ scores of 57 vs 56. The clearest difference is quality, while RLAY has the stronger momentum profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 1 points
RLAY
Healthcare
vs
SLS
Healthcare
RLAY
Relay Therapeutics, Inc.
Price
$18.09
Day move
+0.06%
AIQ Score
56/100
Best edge
Momentum
Sector
Healthcare
SLS
SELLAS Life Sciences Group, Inc.
Leads
Price
$7.86
Day move
-2.12%
AIQ Score
57/100
Best edge
Quality
Sector
Healthcare

What is the main difference between RLAY and SLS?

SLS leads the current stock comparison as SELLAS Life Sciences Group, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Relay Therapeutics, Inc. vs SELLAS Life Sciences Group, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 60/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 2/10

SLS leads

SLS leads by 1 AIQ points, primarily on Quality, but the lead has narrowed from 20 points over 30 sessions.

Fragile: 1 of 4 evidence groups support SLS, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 1 of 4Comparison trend: Weakening
RLAY

Relay Therapeutics, Inc.

AIQ Score
56/100
AIQ Edge Score
5/10
SLS

SELLAS Life Sciences Group, Inc.

Leads
AIQ Score
57/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors SLS over RLAY, 57 versus 56 as of Nov 15, 2026. SLS's advantage is driven primarily by stronger quality, while RLAY holds the stronger momentum profile. SLS also shows the weaker technical structure relative to its 50-day moving average. 1 of 4 covered evidence groups favor SLS today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. SLS lead: Weakening — the AIQ differential moved from 20 to 1 points over 30 sessions.

Compare Relay Therapeutics, Inc. and SELLAS Life Sciences Group, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

RLAY
-49.7%
SLS
+11.2%

Price return comparison

Growth of $10,000, price only

RLAY $5,033 · SLS $11,117

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare RLAY and SLS against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

RLAY advantage
0
SLS advantage
  • Quality47 vs 73
    SLS +26
  • Momentum76 vs 55
    RLAY +21
  • Risk Resilience52 vs 32
    RLAY +20

1 of 4 evidence groups favor SLS. SLS’s edge is concentrated in quality; RLAY keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

RLAY+1 AIQ

Largest factor move: Value +2

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.58x)
SLS0 AIQ

Largest factor move: Momentum +2, not enough on its own to move the overall score.

New signals

  • Distribution Pattern — bearish, volume, medium horizon (1.48x)

SLS's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — RLAY and SLS both carry a full feed there.

The central trade-off

SLS (SELLAS Life Sciences Group, Inc.): the stronger current systematic profile, led by quality.

RLAY (Relay Therapeutics, Inc.): the counter-case, on momentum, risk resilience, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

SLS

SLS on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

SLS

SLS on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

RLAY

RLAY on the Momentum factor, by 21 points.

Lower downside

RLAY

RLAY on Risk Resilience, by 20 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureRLAYSLSNote
Implied upside to target+60.3%—Level
Target dispersion0%—Lower is tighter analyst agreement
ConsensusBuyStrong BuyContext, not a primary driver
Analysts covering132Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

1 of 4 covered evidence groups favor SLS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven56 vs 57
FundamentalsSLSTTM ROE -10% vs -7.7%
ValuationNot coveredNot covered
TechnicalsRLAYPrice vs 50-day -1.5% vs -28.7%; vs 200-day 16.4% vs -10.5%
Risk ResilienceRLAYRisk Resilience 52 vs 32
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of RLAY and SLS and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
  • Only 1 of 4 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has swung materially session to session. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)
  • Signal direction runs against the verdict: the leader is net-bearish while the laggard is net-bullish. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on SLS.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

SLS lead: Weakening — the AIQ differential moved from 20 to 1 points over 30 sessions.

May 27RLAY leads above the line · SLS leads belowNov 13
Today
SLS +1
56 vs 57
7 sessions ago
SLS +10
55 vs 65
30 sessions ago
SLS +20
49 vs 69
90 sessions ago
SLS +16
60 vs 76

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

RLAYConflicted

3 bullish / 2 bearish / 2 neutral, conflicted

Only RLAY

  • ADX Trend Weakening — neutral, trend, medium horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.58x)
  • TRIX Bullish Signal — bullish, momentum, short horizon
SLSConflicted

1 bullish / 2 bearish / 1 neutral, conflicted

Only SLS

  • Distribution Pattern — bearish, volume, medium horizon (1.48x)

Both carry 3 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, Beta Spike Warning.

SLS leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

RLAYNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.06%, AIQ +1 points).

SLSNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.12%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1RLAY closes the Quality gap — currently 26 points behind, the largest single contributor to SLS's edge.
  2. 2RLAY's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3SLS's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 19 points over 30 sessions, and a further 1-point move would eliminate SLS's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

SLS leads on balance
MetricRLAYSLS
Revenue growth (YoY)-100%0%
EPS growth (YoY)9.8%0%
Gross margin89.3%0%
Operating margin-30.9%0%
Return on equity (TTM)-10%-7.7%
Debt to equity0.030

Performance

RLAY leads 5 of 6 windows
MetricRLAYSLS
1 week (5 sessions)-2.7%-6.7%
1 month (20 sessions)11.1%-21.2%
3 months (63 sessions)-12.5%-39.5%
6 months (126 sessions)48.3%11%
Year to date113.8%108.5%
1 year (252 sessions)193.2%427.5%

Technicals

RLAY has the stronger structure
MetricRLAYSLS
RSI (14)47.934.7
ADX (14)14.325.3
Price vs 50-day-1.5%-28.7%
Price vs 200-day16.4%-10.5%
Volatility (1M, annualized)80.3%114.5%

Risk

RLAY is the more resilient
MetricRLAYSLS
Beta1.662.27
Sharpe ratio1.842.04
Sortino ratio3.133.43
Max drawdown-28.2%-49.2%
Current drawdown-12.8%-49.2%
Annualized volatility65.8%109.9%
Value at risk (95%)-5.4%-8.9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, RLAY or SLS?

On the Algovestiq AIQ Score, SLS is the stronger of the two as of Nov 15, 2026, scoring 57 against RLAY's 56. The edge comes from quality. RLAY is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is RLAY or SLS the better buy right now?

SLS carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 1 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.

Why does the AIQ Score favor SLS over RLAY?

The composite weights Quality, Value, Momentum and Risk Resilience. SLS leads Quality by 26 points; RLAY leads Momentum by 21 points; RLAY leads Risk Resilience by 20 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, RLAY or SLS?

Analyst price targets imply +60.3% upside for RLAY and not covered for SLS. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, RLAY or SLS?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, RLAY or SLS?

SLS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, RLAY or SLS?

RLAY on the Momentum factor, by 21 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, RLAY or SLS?

RLAY is the more resilient of the two, so the other name carries the higher downside risk. RLAY on Risk Resilience, by 20 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is RLAY more profitable than SLS?

SLS leads on the comparable margin measures — gross margin 89.3% vs 0%; operating margin -30.9% vs 0%; ttm roe -10% vs -7.7%.

Is SLS's lead over RLAY getting stronger or weaker?

SLS lead: Weakening — the AIQ differential moved from 20 to 1 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the RLAY vs SLS verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RLAY closes the Quality gap — currently 26 points behind, the largest single contributor to SLS's edge; RLAY's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; SLS's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 19 points over 30 sessions, and a further 1-point move would eliminate SLS's advantage entirely.

What do the current signals say about RLAY and SLS?

RLAY: 3 bullish / 2 bearish / 2 neutral, conflicted. SLS: 1 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on RLAY is Golden Cross Active (bullish, long horizon). On SLS it is Golden Cross Active (bullish, long horizon).

Compare RLAY and SLS with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.